Please login to the form below

Not currently logged in
Email:
Password:

Simon Grime joins Fendix Media as commercial director

Moves to the online network of NHS websites from M3

Simon Grime joins Fendix Media as commercial directorFendix Media has appointed Simon Grime as its new commercial director, handing him responsibility for driving the growth of its network of NHS websites.

The Nottinghamshire, UK-based company enables pharma companies and firms from other sectors to use NHS intranets and websites as messaging platforms.

Grime joins Fendix from M3, the owner of the UK's largest online network of doctors Doctors.net.uk, where he served for three years as managing director of its communications business.

He said: “These are exciting times in the digital healthcare landscape and for Fendix Media, and I am very much looking forward to helping the company to capitalise on its unique offering for organisations that want to reach HCPs through one of their most trusted and frequently used channels.”

In Grime's new role his tasks will also include leading the introduction of new advertising products for pharma and other organisations to utilise within the NHS intranets used daily by staff at NHS trusts.

Simon Feeney, director and co-founder of Fendix Media, said: “We're delighted to welcome Simon Grime to our company. He has significant experience in the digital media industry and, in particular, across the healthcare landscape. We look forward to working with him and growing the business from strength to strength."

9th July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....

Infographics